肌成纤维细胞
纤维化
肾
成纤维细胞
癌症研究
染色体易位
细胞生物学
串扰
化学
上皮-间质转换
下调和上调
体外
生物
信号转导
心脏纤维化
医学
机制(生物学)
囊性纤维化
作者
Yajun Luo,Aoqi Kang,Guoqing Zhang,Yong Xu,Tao Zhang,Xiaoyan Wu
摘要
Resident renal fibroblasts are a predominant source for myofibroblasts that produce ECM to contribute to renal fibrosis in the course of chronic kidney disease (CKD). The mechanism whereby fibroblast-myofibroblast transition (FMyT) is driven remains incompletely understood. In the present study, we investigated the involvement of ten-eleven translocation 3 (TET3) in regulating FMyT and renal fibrosis focusing on the regulatory mechanism and translational potential. We report that TET3 deletion in primary renal fibroblasts dampened myofibroblast transition in response to pro-fibrogenic stimuli. Consistently, conditional deletion of TET3 in quiescent fibroblasts (driven by the Col1a2-Cre) or in myofibroblasts (driven by the Postn-Cre) equally attenuated renal fibrosis in mice. Integrated transcriptomic analysis combining RNA-seq and CUT&Tag-seq uncovered signal peptide CUB-EGF-like domain-containing protein 3 (Scube3) as a novel downstream target for TET3. Co-culture assay confirmed that Scube3 mediated intercellular crosstalk and promoted fibroblast activation in an autocrine/paracrine manner. Importantly, myofibroblast-specific Scube3 depletion significantly ameliorated renal fibrosis in mice. Finally, a small-molecule TET3 degrader Bobcat339 suppressed FMyT in vitro and mitigated renal fibrosis in vivo. Our data support a role for TET3 in renal fibrosis and provide proof-of-concept that targeting the TET3-Scube3 axis may yield novel therapeutic solutions for treating CKD.
科研通智能强力驱动
Strongly Powered by AbleSci AI